NCT07007611Completed
The Role of Surgical Resection AND Stereotactic Radiosurgery in Primary Central Nervous System -Diffuse Large B Cell Lymphoma
The Role of Surgical Resection AND Stereotactic Radiosurgery in PCNS-DLBCL: A Retrospective Analysis of Clinical Benefits
Source: ClinicalTrials.gov · Last updated 11 Jun 2025
Brief summary (registry, in English)
The objective of this observational study is to understand the long-term impact of surgery and gamma knife treatment on primary central diffuse large B-cell lymphoma. The main questions it aims to answer are: Can surgery and gamma knife prolong the survival period of patients with primary central diffuse large B-cell lymphoma? Participants who have already incorporated surgery and gamma knife as part of the routine medical care for patients with primary central diffuse large B-cell lymphoma will answer questions about survival period within 5 years.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 76 (actual)
- First submitted
- 28 May 2025
- Start date
- 1 Dec 2006
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- jiahong Deng
- NCT number
- NCT07007611
What you commit to
- Study type: Observational
- Participants enrolled: 76
- From 1 Dec 2006 to the primary completion date, 1 Dec 2023
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- incomplete systemic treatment data loss to follow-up after initial contact prior receipt of whole-brain radiotherapy.
Who the study is looking for
- pathologically confirmed PCNS-DLBCL complete clinical records detailing treatment methods and surgical approaches.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.